Wolverine Trading
PACB icon

Wolverine Trading’s Pacific Biosciences PACB Stock Holding History

Wolverine Trading’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$80.4K Sell
64,300
-17,900
-22% -$24.2K ﹤0.01% 5281
2025
Q2 		$106K Buy
82,200
+6,800
+9% +$7.85K ﹤0.01% 4152
2025
Q1 		$86K Buy
75,400
+23,800
+46% +$36.5K ﹤0.01% 4267
2024
Q4 		$92.4K Buy
51,600
+28,300
+121% +$55.2K ﹤0.01% 4826
2024
Q3 		$40.8K Sell
23,300
-4,300
-16% -$7.07K ﹤0.01% 4569
2024
Q2 		$37.8K Buy
27,600
+100
+0.4% +$202 ﹤0.01% 4261
2024
Q1 		$103K Buy
27,500
+16,800
+157% +$98.4K ﹤0.01% 4040
2023
Q4 		$105K Sell
10,700
-1,600
-13% -$13.1K ﹤0.01% 4094
2023
Q3 		$103K Sell
12,300
-18,700
-60% -$214K ﹤0.01% 3989
2023
Q2 		$407K Buy
31,000
+14,100
+83% +$171K ﹤0.01% 2802
2023
Q1 		$165K Buy
+16,900
New +$168K ﹤0.01% 3506
2019
Q1 		– Sell
-23,900
Closed -$175K – 5095
2018
Q4 		$175K Sell
23,900
-2,100
-8% -$13.3K ﹤0.01% 3770
2018
Q3 		$141K Buy
+26,000
New +$112K ﹤0.01% 4416
2017
Q4 		– Sell
-23,100
Closed -$121K – 5328
2017
Q3 		$121K Buy
+23,100
New +$99.3K ﹤0.01% 4012
2017
Q2 		– Sell
-18,200
Closed -$94K – 4779
2017
Q1 		$94K Buy
18,200
+4,000
+28% +$19.6K ﹤0.01% 3840
2016
Q4 		$54K Sell
14,200
-8,600
-38% -$62.5K ﹤0.01% 4199
2016
Q3 		$201K Sell
22,800
-5,800
-20% -$48.5K ﹤0.01% 3828
2016
Q2 		$210K Buy
+28,600
New +$261K ﹤0.01% 3231

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return

Wolverine Trading's PACB Position: Q3 2025 in Review

Wolverine Trading reduced its Pacific Biosciences (PACB) stake by 3.2% in Q3 2025, selling an estimated $2.64K and leaving 59,213 shares worth $74K. The position accounts for ﹤0.01% of the portfolio, ranked #5316.

Wolverine Trading first reported a position in PACB in Q2 2016 and has held it in 12 quarters since. The position peaked at $250K in Q2 2016. 208 funds tracked by Wall St. Rank hold PACB as of Q3 2025.

  • Wolverine Trading held 59,213 shares of Pacific Biosciences worth $74K as of Q3 2025.
  • Wolverine Trading sold 1,952 Pacific Biosciences shares in Q3 2025, an estimated $2.64K.
  • Pacific Biosciences made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5316 holding.
  • Wolverine Trading first reported a position in Pacific Biosciences in Q2 2016 and has held it in 12 quarters since.
  • Wolverine Trading's Pacific Biosciences position peaked at $250K in Q2 2016.
  • 208 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.